Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report

As reported by NDTV Profit - Latest

India's largest drugmaker by market capitalisation is expected to sell bonds with maturities of two, three and four years.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

INDIAN Infosys, Wipro shares crash to 6-year lows as IT sell-off gathers pace; what is weighing on the sector? mint - markets
INDIAN Vedanta's demerger report card: Vedanta Iron to Vedanta Power - Who gained, who lagged since listing? Check real winner mint - markets
INDIAN Nomura sees earnings resilience, but oil, geopolitics weigh on valuations Share Market Today
INDIAN Gold slips below ₹1.5 lakh per 10g in Delhi for the first time in 2 months Share Market Today
GLOBAL US ban on Canadian alcohol and dairy takes effect as trade war drags on BBC News
INDIAN New Foreign Car Companies Aren't Localising | The Reason Why NDTV Profit - Latest
INDIAN ITC Takes Full Ownership Of Yoga Bar Parent With Rs 645-Crore Additional Stake Purchase NDTV Profit - Latest
INDIAN Tata Steel Infuses Rs 3,260 Crore In Singapore Arm T Steel Holdings Via Equity Mop-Up NDTV Profit - Latest

Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report

More from Market Samachar